GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: MED
Outperform $34

Medifast Inc (NYSE: MED) reiterated to Outperform with price target $34 by Imperial Capital

Friday,  Aug 8, 2014  12:00 AM ET by Betsy O'Brien Harrison

Imperial Capital reiterated Medifast Inc (NYSE: MED) to Outperform with price target
$34. Previously Imperial Capital reiterated Medifast Inc (NYSE: MED) to Outperform with price target $30 on 09/06/2013, when the stock price was $26.14.

Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. The Company?s product lines include weight and disease management, meal replacement, and vitamins primarily manufactured in its modern, the United States Food and Drug Administration (FDA) approved facility in Owings Mills, Maryland. The Company?s operations are primarily conducted through five of its wholly owned subsidiaries, Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSF), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. The Company offers a variety of weight and disease management products under the Medifast brand and for select private label customers. It's distribution channels include Medifast Direct, Take Shape for Life, Medifast Weight Control Centers and Medifast Physicians.

Imperial Capital



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy